What type of study is this?

This is a In Vitro Study study.

What question did this study set out to answer?

This research aims to explore the mechanisms behind chemotherapy resistance in NPM1 mutant acute myeloid leukemia (AML).

December 8, 2025Blood

View Full Paper

Ask AI

Bookmark

This research aims to explore the mechanisms behind chemotherapy resistance in NPM1 mutant acute myeloid leukemia (AML).
Enrolled forty NPM1 mutant AML patients for single-cell RNA-sequencing analysis.
Conducted flow cytometry to validate chemoresistant leukemic subpopulations.
Performed high-throughput screening of clinical compounds to identify potential therapeutic targets.
Executed pathway enrichment analysis and shRNA-mediated knockdown in NPM1 mutant AML cell lines.
Identified a chemoresistant monocyte-like leukemia stem cell population correlated with poor prognosis.
Demonstrated that NPM1 mutant AML cells suppress CD8+ T cell function through TGF-β1 secretion.
Highlighted the MAPK pathway's role in driving therapy resistance, with inhibitors enhancing chemotherapy response.

No takes yet. Share an insight, caveat, or question.

Single-cell RNA-sequencing reveals chemoresistant leukemia stem cells in NPM1 mutant AML, suggesting new immunotherapy targets.

Jia et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark